The Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, announced on the 17th that it ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...
The move came after the FDA approved updated shots only for people aged 65 and over and those at risk of severe disease. The ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
An example of this conflict occurred in the 1920s when Trofim Lysenko, a Soviet biologist, rejected natural selection in ...
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...